Ligand validation:8FUX

KDO: 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8FUX_KDO_A_405	97%	8%	0.054	0.982	2.76	1.86	3	8	0	0	94%	0.9375
8FUX_KDO_B_404	56%	31%	0.125	0.908	1.3	1.42	2	5	0	0	94%	0.7022
8FUW_KDO_A_502	33%	20%	0.138	0.828	1.93	1.44	3	5	1	0	94%	0.7556
3DUR_KDO_A_303	100%	29%	0.021	0.994	1.55	1.32	3	2	0	0	100%	1
3DUU_KDO_B_114	100%	43%	0.022	0.993	1.01	1.21	1	1	0	0	100%	1
3DUS_KDO_C_108	100%	46%	0.034	0.985	1	1.09	1	1	0	0	100%	1
3K8D_KDO_D_1244	96%	10%	0.064	0.983	2.6	1.77	6	6	0	1	94%	0.9375
3DUV_KDO_A_263	95%	24%	0.052	0.955	0.95	2.11	1	4	0	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.